Dutch Saillant Therapeutics to develop generic virus inhibiting therapy based on activation of a cellular master regulator, ending virus replication Nijmegen, The Netherlands, 11 August 2020 -- Saillant Therapeutics, an innovative biotechnology start-up, developing...